TetraLogic Pharmaceuticals (OTCMKTS:TLOG) Stock Price Passes Above 50 Day Moving Average – Here’s Why

Shares of TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG) crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.00 and traded as high as $0.0001. TetraLogic Pharmaceuticals shares last traded at $0.00, with a volume of 0 shares trading hands.

TetraLogic Pharmaceuticals Stock Down 100.0%

About TetraLogic Pharmaceuticals

TetraLogic Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel immunotherapies and small-molecule therapeutics for the treatment of cancer and infectious diseases. Its primary focus is on synthetic carbohydrate-based vaccines that stimulate targeted immune responses against tumor-associated antigens, complemented by a small-molecule antibiotic platform designed to combat drug-resistant bacterial pathogens.

The company’s lead immunotherapy candidate, which targets mucin-based tumor antigens, is under evaluation in early-phase clinical trials in collaboration with academic research centers, with particular emphasis on breast and ovarian cancer indications.